|
SP100 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.173560E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.171600E-02 |
| Normal-vs-Stage2 |
6.930200E-02 |
| Normal-vs-Stage3 |
2.027400E-01 |
| Normal-vs-Stage4 |
6.212400E-02 |
| Stage1-vs-Stage2 |
2.14729999999941E-05 |
| Stage1-vs-Stage3 |
3.031200E-01 |
| Stage1-vs-Stage4 |
7.607400E-01 |
| Stage2-vs-Stage3 |
1.322190E-03 |
| Stage2-vs-Stage4 |
1.056270E-03 |
| Stage3-vs-Stage4 |
3.299800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.758300E-02 |
| Normal-vs-AfricanAmerican |
5.568000E-02 |
| Normal-vs-Asian |
1.675960E-03 |
| Caucasian-vs-AfricanAmerican |
4.075200E-01 |
| Caucasian-vs-Asian |
3.717900E-02 |
| AfricanAmerican-vs-Asian |
5.104000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.230500E-02 |
| Normal-vs-Female |
1.527630E-01 |
| Male-vs-Female |
5.808200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.676600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.418040E-01 |
| Normal-vs-Age(61-80Yrs) |
6.564400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.458200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.862400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.998250E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.483700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.930310E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.255550E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.117200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.605400E-01 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
7.462400E-01 |
| Classical-VS-Normal |
7.385000E-04 |
| Tall-VS-Follicular |
1.29769999968055E-07 |
| Tall-VS-Other |
5.568800E-01 |
| Tall-VS-Normal |
6.504800E-03 |
| Follicular-VS-Other |
1.985740E-02 |
| Follicular-VS-Normal |
2.200700E-03 |
| Other-VS-Normal |
3.184800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.832800E-01 |
| Normal-vs-N1 |
9.284100E-02 |
| N0-vs-N1 |
5.344300E-02 |
|
|
